-
After Trials on 703 Patients, Fruquintinib's Application is Rejected, OS Data Proves to Be a Roadblo...
On August 30, HUTCHMED officially announced that it had voluntarily withdrawn its marketing application for fuquinitinib for second-line gastric cance...
2024-09-03 17:40 -
UCB sells mature Chinese business in a package, Middle East and Singapore capital jointly take over ...
UCB, a Belgian-based biopharmaceutical company, will sell its mature neurology and allergy business in China to Singapore-based asset management group...
2024-09-03 14:31 -
Hengrui Pharmaceuticals: The Innovation Dilemma Behind the €160 Million Windfall, as the Supercarri...
On August 21, 2024, Hengrui Pharmaceutical announced its remarkable financial results: in the half year, the company's revenue reached 13.601 billion ...
2024-09-02 17:28 -
Johnson & Johnson's New Drug Comes Under Fire: 4.7-Point Improvement Fails to Ease the Plight of gMG...
The study was a double-blind, placebo-controlled trial that enrolled a large number of patients with AChR+, MuSK+, and/or LRP4+, who accounted for app...
2024-09-02 17:27 -
Sanofi's Diabetes Drug Raises Concerns, Type1 Diabetes Treatment May Be a Trap: Can It Really Delay ...
On August 28, the Center for Drug Evaluation (CDE) under the National Medical Products Administration (NMPA) of China announced on its official websit...
2024-09-02 17:27 -
Merck's PD-1 Miracle Drug Keytruda Faces Setback: Three Studies on Lung and Skin Cancer Announce Fai...
The interim analysis showed that the combination of Keytruda and stereotactic radiotherapy (SBRT) did not significantly improve event-free survival or...
2024-09-02 17:26 -
Paraguay Cautions: Top 4 Health Supplement Blacklists Revealed - Unregistered and Unregulated Produc...
The National Health Supervision Agency made it clear that the above-mentioned products lacked scientific evidence to support their efficacy and were n...
2024-08-30 17:20 -
Eli Lilly's Market Cap Breaks $90 Billion: Can the New AD Drug Donanemab Break the 99.6% Failure Rat...
In the second quarter of 2024, Lilly showed strong growth momentum, with revenue of $20 billion in the first half of the year, up 31% year-on-year, ne...
2024-08-30 17:19 -
Europe's First Alzheimer's Disease Drug, Lecanemab, Approved, But 18-Month Study Reveals 5 Potential...
The drug is indicated for adult patients regardless of whether they are heterozygotes or non-carriers of apolipoprotein E ε4 (ApoE ε4).
2024-08-30 17:18 -
Behind Kenvue's Win as Tylenol Manufacturer: Consumers Deceived by 'Sky-High' Rapid Release Gel That...
Kenvue, the maker of Tylenol, has won a class action lawsuit against U.S. consumers.
2024-08-29 17:20
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
